Ignite Creation Date:
2025-12-24 @ 9:36 PM
Ignite Modification Date:
2026-02-24 @ 1:15 AM
Study NCT ID:
NCT01629732
Status:
WITHDRAWN
Last Update Posted:
2014-05-09
First Post:
2012-06-26
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase 2b Study of BMS-986094 and Daclatasvir, With or Without Ribavirin for the Treatment of Patients With Chronic Hepatitis C
Sponsor:
Bristol-Myers Squibb
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-03
Start Date Type:
None
Primary Completion Date:
2014-02
Primary Completion Date Type:
ESTIMATED
Completion Date:
2014-06
Completion Date Type:
ESTIMATED
First Submit Date:
2012-06-26
First Submit QC Date:
None
Study First Post Date:
2012-06-28
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-05-08
Last Update Post Date:
2014-05-09
Last Update Post Date Type:
ESTIMATED